Drug Channels Institute (DCI) is a leading source of industry research about pharmaceutical economics and the drug distribution system. >

Industry Reports

The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

The ultimate guide to the complex web of interactions within the U.S. prescription distribution and reimbursement system more >

The 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

The most comprehensive tool for analyzing the economic and business realities of the U.S. pharmaceutical distribution industry. more >

From The Drug Channels Blog

The State of Employer Pharmacy Benefits in 2026: When Plan Savings Come From Higher Patient Costs

By Bryce Platt, PharmD Employers pharmacy benefit design changes determine who pays for a prescription and who gets the savings. Lower net plan liability on more >

BlinkRx Insights: Clarifying the Mystery around “DTP”

Today's guest post comes from Geoff Chaiken, CEO at BlinkRx. Geoff examines the different roles of telemedicine, consumer rebates through cash discount cards, and cash-pay pharmacies in direct-to-patient (DTP) more >